NCT03922542View on ClinicalTrials.gov

Comparison of Standard vs. Accelerated Corneal Crosslinking

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

510

Participants

Timeline

Start Date

April 16, 2019

Primary Completion Date

June 1, 2026

Study Completion Date

July 1, 2026

Conditions
KeratoconusEctasia Corneal
Interventions
COMBINATION_PRODUCT

riboflavin 0.1%

Use of riboflavin 0.1% eye drops and 9 mW/cm2 UVA light for 10 minutes

COMBINATION_PRODUCT

Riboflavin 0.1%

Use of riboflavin 0.1% eye drops and 3 mW/cm2 UVA light for 30 minutes

Trial Locations (1)

46260

RECRUITING

Price Vision Group, Indianapolis

All Listed Sponsors
lead

Price Vision Group

INDUSTRY